KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Revenue (2016 - 2025)

Historic Revenue for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $151.7 million.

  • Opko Health's Revenue rose 52933.2% to $151.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $642.1 million, marking a year-over-year increase of 1427.16%. This contributed to the annual value of $713.1 million for FY2024, which is 1741.21% down from last year.
  • As of Q3 2025, Opko Health's Revenue stood at $151.7 million, which was up 52933.2% from $156.8 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Revenue registered a high of $545.2 million during Q1 2021, and its lowest value of $1.0 million during Q3 2021.
  • For the 5-year period, Opko Health's Revenue averaged around $212.9 million, with its median value being $181.9 million (2023).
  • Per our database at Business Quant, Opko Health's Revenue plummeted by 9976.64% in 2021 and then skyrocketed by 1787440.0% in 2022.
  • Opko Health's Revenue (Quarter) stood at $401.3 million in 2021, then tumbled by 53.82% to $185.3 million in 2022, then decreased by 1.85% to $181.9 million in 2023, then increased by 0.95% to $183.6 million in 2024, then dropped by 17.41% to $151.7 million in 2025.
  • Its Revenue was $151.7 million in Q3 2025, compared to $156.8 million in Q2 2025 and $150.0 million in Q1 2025.